Bacteremia induced by Bifidobacterium breve in a newborn with cloacal exstrophy

Pediatrics International

Volumn 58, Issue 11, 2016, Pages 1226-1228

  Sato, Shinichi ^a   Uchida, Toshihiko ^a   Kuwana, Shota ^a   Sasaki, Kazuto ^a   Watanabe, Tatsuya ^a   Saito, Junko ^a   Kawaji, Takahiro ^a  

^a MIYAGI CHILDREN S HOSPITAL   (Japan)

Author keywords

bacteremia; bacterial translocation; BBG 01; Bifidobacterium breve; probiotic

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; C REACTIVE PROTEIN; CEFAZOLIN; CEFMETAZOLE; CLINDAMYCIN; ENEMA; FLOMOXEF; IMIPENEM; PENICILLIN DERIVATIVE; TOSUFLOXACIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL DISEASE; ABDOMINAL DISTENSION; ADULT; ANTIBIOTIC SENSITIVITY; ANUS ATRESIA; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM CULTURE; BIFIDOBACTERIUM BREVE; CASE REPORT; CLOACAL EXSTROPHY; CONGENITAL MALFORMATION; CONSTIPATION; CYSTOURETHROPLASTY; DISEASE ASSOCIATION; ECHOGRAPHY; ENTERIC FEEDING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEUS; INFANT; INTESTINE OBSTRUCTION; MALE; NEWBORN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OMPHALOCELE; ONSET AGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STOMACH JUICE; URETHROPLASTY; BLADDER EXSTROPHY; COMPLICATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREGNANCY; YOUNG ADULT;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BIFIDOBACTERIUM BREVE; BLADDER EXSTROPHY; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; YOUNG ADULT;

EID: 84996477576     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.13103     Document Type: Article

References (9)

1. Ishikawa H, Matsumoto S, Ohashi Y et al. Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study. Digestion 2011; 84: 128–33.
2. Kanamori Y, Sugiyama M, Hashizume K, Yuki N, Morotomi M, Tanaka R. Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. J. Pediatr. Surg. 2004; 39: 1686–92.
3. Enomoto T, Sowa M, Nishimori K et al. Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol. Int. 2014; 63: 575–85.
4. Kitajima H, Sumida Y, Tanaka R, Yuki N, Takayama H, Fujimura M. Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 1997; 76: F101–7.
5. Kanamori Y, Iwanaka T, Sugiyama M et al. Early use of probiotics is important therapy in infants with severe congenital anomaly. Pediatr. Int. 2010; 52: 362–7.
6. Ohishi A, Takahashi S, Ito Y et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J. Pediatr. 2010; 156: 679–81.
7. Balzan S, Almeida Quadros CA, de Cleva R, Zilberstein B, Cecconello I. Bacterial translocation: overview of mechanisms and clinical impact. J. Gastroenterol. Hepatol. 2007;22:464–71.
8. Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice: what are the risks. Am. J. Clin. Nutr. 2006; 83: 1256–64.
9. Remington JS, Klein JO, Wilson CB et al. Infectious Diseases of the Fetus and Newborn Infant, 7th edn. Saunders, Philadelphia, 2011.